MetMAb News (2 articles)
|
|
MetMAb in combination with Tarceva doubled the time people with lung cancer lived without their disease getting worseRoche’s investigational personalised medicine showed promising final Phase II results in people with a form of lung cancer.Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced final results from a randomised, multicentre, double-blind Phase II study with its investigational personalised... Published on 19 May 2011, 04:17 |
MetMAb, a new compound under investigation, extends the time people with lung cancer live without their disease getting worseImportant new data in lung cancer presented at ESMO, including further evidence of strong efficacy of Tarceva in lung cancer with genetic mutations MetMAb plus Tarceva in lung cancer patients: preliminary data showed a pre-specified group of patients lived nearly twice as long without... Published on 11 October 2010, 08:18 |
|
Top Categories
We have launched our peer- reviewed, Open-access journal: Insciences Journal
Recently added
27.11.12
Consequential Life Cycle Assessment of Nitrogen Fertilisers Based on Biomass – a Swedish perspective
08.11.12
From Molecular Hollows to Imprinting Strategies – Mass-Sensitive Devices in Host-Guest Chemistry
26.04.12
CdSe/ZnSe Quantum-Dot Semiconductor Optical Amplifiers
23.03.12
Screen-printed Electrochemical Sensors and Biosensors for Monitoring Metal Pollutants